Kazia Therapeutics
KZIA
12 hedge funds and large institutions have $4.6M invested in Kazia Therapeutics in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 5 closing their positions.
12% more capital invested
Capital invested by funds: $4.12M → $4.6M (+$485K)
0% less ownership
Funds ownership: 0.01% → 0.01% (-0%)
8% less funds holding
Funds holding: 13 → 12 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
38% less call options, than puts
Call options by funds: $433K | Put options by funds: $704K
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$535K |
| 2 |
SG Americas Securities
New York
|
+$414K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$254K |
| 4 |
TCWM
Total Clarity Wealth Management
St. Charles,
Illinois
|
+$18.8K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.05K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Atom Investors
Austin,
Texas
|
-$857K |
| 2 |
Renaissance Technologies
New York
|
-$594K |
| 3 |
HAG
HighPoint Advisor Group
Downers Grove,
Illinois
|
-$368K |
| 4 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$83.7K |
| 5 |
Truist Financial
Charlotte,
North Carolina
|
-$75.8K |
KZIA Hedge Fund Activity: Q1 2021 in Review
12 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q1 2021, worth a combined $4.6M — up 12% from $4.12M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of KZIA and 4 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 1 added.
The largest buyer was Morgan Stanley, adding an estimated $535K. The largest seller was Atom Investors, exiting entirely with an estimated $857K sold.
- 12 institutional investors held Kazia Therapeutics (KZIA) as of Q1 2021, down from 13 in Q4 2020.
- Funds reported $4.6M of Kazia Therapeutics stock for Q1 2021, up 12% quarter-over-quarter.
- 4 funds opened new Kazia Therapeutics positions in Q1 2021 and 5 closed out, a net change of -1 holder.
- The largest Kazia Therapeutics buyer in Q1 2021 was Morgan Stanley, an estimated $535K added.
- The largest Kazia Therapeutics seller in Q1 2021 was Atom Investors, an estimated $857K sold.
Based on aggregated 13F filings for Q1 2021.